UChicago Breast and Lymphedema Symposium 2019
Abemaciclib + Anastrozole Are Effective With Manageable Toxicities in HR+/HER2- Early Breast Cancer / Neoadjuvant Pertuzumab and Trastuzumab in HER2+ Breast Cancer and Long Term Efficacy
By
UChicago Breast and Lymphedema Symposium 2019
FEATURING
Rita Nanda
By
UChicago Breast and Lymphedema Symposium 2019
FEATURING
Rita Nanda
Comments 0
Login to view comments.
Click here to Login
